Avanza Fonder AB Sells 2,905 Shares of Humana Inc. $HUM

Avanza Fonder AB lowered its position in shares of Humana Inc. (NYSE:HUM) by 30.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,622 shares of the insurance provider’s stock after selling 2,905 shares during the period. Avanza Fonder AB’s holdings in Humana were worth $1,696,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Rosenberg Matthew Hamilton grew its stake in Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 68 shares during the last quarter. Elevation Point Wealth Partners LLC purchased a new position in Humana in the 2nd quarter worth $32,000. Mather Group LLC. purchased a new position in shares of Humana in the third quarter worth about $34,000. AlphaCore Capital LLC acquired a new position in Humana during the second quarter valued at $39,000. Finally, Private Wealth Management Group LLC lifted its holdings in shares of Humana by 47.5% in the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock valued at $39,000 after buying an additional 48 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on HUM shares. Royal Bank Of Canada lowered shares of Humana from an “outperform” rating to a “sector perform” rating and lowered their target price for the stock from $322.00 to $189.00 in a research note on Thursday, February 12th. Evercore dropped their target price on shares of Humana from $260.00 to $180.00 in a report on Thursday, February 12th. Wolfe Research raised their price objective on shares of Humana from $300.00 to $325.00 and gave the stock an “outperform” rating in a research report on Thursday, January 8th. Truist Financial reduced their target price on shares of Humana from $285.00 to $200.00 and set a “hold” rating on the stock in a research note on Tuesday, February 17th. Finally, Cantor Fitzgerald decreased their target price on shares of Humana from $290.00 to $201.00 and set a “neutral” rating on the stock in a report on Thursday, February 12th. Seven equities research analysts have rated the stock with a Buy rating, sixteen have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $225.48.

Humana Trading Up 1.2%

Shares of NYSE HUM opened at $172.25 on Wednesday. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $20.68 billion, a PE ratio of 17.54, a PEG ratio of 1.82 and a beta of 0.44. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $315.35. The stock has a fifty day simple moving average of $197.99 and a 200-day simple moving average of $240.78.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.01) by $0.05. Humana had a return on equity of 11.43% and a net margin of 0.92%.The firm had revenue of $32.64 billion for the quarter, compared to analyst estimates of $32.08 billion. During the same quarter in the prior year, the company earned ($2.16) EPS. Humana’s revenue was up 11.3% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, equities analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 27th. This represents a $3.54 annualized dividend and a dividend yield of 2.1%. Humana’s dividend payout ratio (DPR) is presently 36.05%.

Insider Buying and Selling at Humana

In other Humana news, insider Sanjay K. Shetty acquired 810 shares of the company’s stock in a transaction that occurred on Monday, February 23rd. The stock was purchased at an average price of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the acquisition, the insider owned 11,657 shares of the company’s stock, valued at approximately $2,158,992.97. This trade represents a 7.47% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.20% of the company’s stock.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.